Integrative Multi-Omics Profiling of Rhabdomyosarcoma Subtypes Reveals Distinct Molecular Pathways and Biomarker Signatures
Cells · 2025
DOI: 10.3390/cells14141115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Aya Osama und 11 weiteren Autor:innen. Beteiligte Einrichtung: Proteomics and Metabolomics Unit, Basic Research Department, Children's Cancer Hospital (CCHE-57357), Cairo 57357, Egypt. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Proteomics, Metabolomics, Rhabdomyosarcoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Egyptian Cancer Network (ECN), USA, Children’s Cancer Hospital 57357, Egypt.
Abstract (Originalsprache)
Rhabdomyosarcoma (RMS), the most common pediatric soft tissue sarcoma, comprises embryonal (ERMS) and alveolar (ARMS) subtypes with distinct histopathological features, clinical outcomes, and therapeutic responses. To better characterize their molecular distinctions, we performed untargeted plasma proteomics and metabolomics profiling in children with ERMS (n = 18), ARMS (n = 17), and matched healthy controls (n = 18). Differential expression, functional enrichment (GO, KEGG, RaMP-DB), co-expression network analysis (WGCNA/WMCNA), and multi-omics integration (DIABLO, MOFA) revealed distinct molecular signatures for each subtype. ARMS displayed elevated oncogenic and stemness-associated proteins (e.g., cyclin E1, FAP, myotrophin) and metabolites involved in lipid transport, fatty acid metabolism, and polyamine biosynthesis. In contrast, ERMS was enriched in immune-related and myogenic proteins (e.g., myosin-9, SAA2, S100A11) and metabolites linked to glutamate/glycine metabolism and redox homeostasis. Pathway analyses highlighted subtype-specific activation of PI3K-Akt and Hippo signaling in ARMS and immune and coagulation pathways in ERMS. Additionally, the proteomics and metabolomics datasets showed association with clinical parameters, including disease stage, lymph node involvement, and age, demonstrating clear molecular discrimination consistent with clinical observation. Co-expression networks and integrative analyses further reinforced these distinctions, uncovering coordinated protein–metabolite modules. Our findings reveal novel, subtype-specific molecular programs in RMS and propose candidate biomarkers and pathways that may guide precision diagnostics and therapeutic targeting in pediatric sarcomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Proteomics and Metabolomics Unit, Basic Research Department, Children's Cancer Hospital (CCHE-57357), Cairo 57357, Egypt.
- Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.
- Radio Diagnosis Department, Children's Cancer Hospital (CCHE-57357), Cairo 57357, Egypt.
- Faculty of Medicine, Beni-Suef University, Beni-Suif 62521, Egypt.
- Pathology Department, Children's Cancer Hospital (CCHE-57357), Cairo 57357, Egypt.
- National Cancer Institute, Cairo University, Cairo 11562, Egypt.
ORCID-Profile: Abdelrahman Atef, Menna Arafat, Rahma W Afifi, Taghreed Khaled Abdelmoneim, Emad Elzayat, Sameh Magdeldin
Förderung
- Egyptian Cancer Network (ECN), USA
- Children’s Cancer Hospital 57357, Egypt
Zitieren
APA
Osama, A., Karam, A., Atef, A., Arafat, M., Afifi, R. W., Mokhtar, M., Abdelmoneim, T. K., Ramzy, A., El Nadi, E., Salama, A., Elzayat, E., & Magdeldin, S. (2025). Integrative Multi-Omics Profiling of Rhabdomyosarcoma Subtypes Reveals Distinct Molecular Pathways and Biomarker Signatures. Cells. https://doi.org/10.3390/cells14141115
Vancouver
Osama A, Karam A, Atef A, Arafat M, Afifi RW, Mokhtar M, et al. Integrative Multi-Omics Profiling of Rhabdomyosarcoma Subtypes Reveals Distinct Molecular Pathways and Biomarker Signatures. Cells. 2025. doi:10.3390/cells14141115
BibTeX
@article{Osama2025,
author = {Osama, Aya and Karam, Ahmed and Atef, Abdelrahman and Arafat, Menna and Afifi, Rahma W and Mokhtar, Maha and Abdelmoneim, Taghreed Khaled and Ramzy, Asmaa and El Nadi, Enas and Salama, Asmaa and Elzayat, Emad and Magdeldin, Sameh},
title = {Integrative Multi-Omics Profiling of Rhabdomyosarcoma Subtypes Reveals Distinct Molecular Pathways and Biomarker Signatures},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14141115}
}
EUVIMED